Department of Genetics, UCL Institute of Ophthalmology, University College London, 11-43 Bath Street, London, EC1V 9EL, UK.
Moorfields Eye Hospital NHS Foundation Trust, London, EC1V 2PD, UK.
Orphanet J Rare Dis. 2020 Nov 26;15(1):333. doi: 10.1186/s13023-020-01613-3.
The crystalline lens is mainly composed of a large family of soluble proteins called the crystallins, which are responsible for its development, growth, transparency and refractive index. Disease-causing sequence variants in the crystallins are responsible for nearly 50% of all non-syndromic inherited congenital cataracts, as well as causing cataract associated with other diseases, including myopathies. To date, more than 300 crystallin sequence variants causing cataract have been identified.
Here we aimed to identify the genetic basis of disease in five multi-generation British families and five sporadic cases with autosomal dominant congenital cataract using whole exome sequencing, with identified variants validated using Sanger sequencing. Following bioinformatics analysis, rare or novel variants with a moderate to damaging pathogenicity score, were filtered out and tested for segregation within the families.
We have identified 10 different heterozygous crystallin variants. Five recurrent variants were found: family-A, with a missense variant (c.145C>T; p.R49C) in CRYAA associated with nuclear cataract; family-B, with a deletion in CRYBA1 (c.272delGAG; p.G91del) associated with nuclear cataract; and family-C, with a truncating variant in CRYGD (c.470G>A; W157*) causing a lamellar phenotype; individuals I and J had variants in CRYGC (c.13A>C; T5P) and in CRYGD (c.418C>T; R140*) causing unspecified congenital cataract and nuclear cataract, respectively. Five novel disease-causing variants were also identified: family D harboured a variant in CRYGC (c.179delG; R60Qfs*) responsible for a nuclear phenotype; family E, harboured a variant in CRYBB1 (c.656G>A; W219*) associated with lamellar cataract; individual F had a variant in CRYGD (c.392G>A; W131*) associated with nuclear cataract; and individuals G and H had variants in CRYAA (c.454delGCC; A152del) and in CRYBB1 (c.618C>A; Y206*) respectively, associated with unspecified congenital cataract. All novel variants were predicted to be pathogenic and to be moderately or highly damaging.
We report five novel variants and five known variants. Some are rare variants that have been reported previously in small ethnic groups but here we extend this to the wider population and record a broader phenotypic spectrum for these variants.
晶状体主要由一大类可溶性蛋白组成,称为晶体蛋白,这些蛋白负责其发育、生长、透明度和折射率。晶体蛋白中的致病序列变异导致近 50%的所有非综合征性遗传性先天性白内障,以及与其他疾病相关的白内障,包括肌病。迄今为止,已经发现了 300 多种导致白内障的晶体蛋白序列变异。
在这里,我们使用全外显子组测序,旨在鉴定 5 个英国家族和 5 个常染色体显性先天性白内障散发病例的疾病遗传基础,使用 Sanger 测序验证鉴定的变体。经过生物信息学分析,从中筛选出罕见或新的具有中度至破坏性致病性评分的变体,并在家族中进行验证。
我们已经鉴定出 10 种不同的晶体蛋白变异。发现了 5 种重复变异:家族 A,CRYAA 上的错义变异(c.145C>T;p.R49C)与核白内障有关;家族 B,CRYBA1 缺失(c.272delGAG;p.G91del)与核白内障有关;家族 C,CRYGD 上的截断变异(c.470G>A;W157*)导致板层状表型;个体 I 和 J 在 CRYGC(c.13A>C;T5P)和 CRYGD(c.418C>T;R140*)上有变异,分别导致不明原因的先天性白内障和核白内障。还鉴定出 5 种新的致病变异:家族 D 在 CRYGC(c.179delG;R60Qfs*)上有变异,与核表型有关;家族 E,CRYBB1(c.656G>A;W219*)上有变异,与板层状白内障有关;个体 F 在 CRYGD(c.392G>A;W131*)上有变异,与核白内障有关;个体 G 和 H 在 CRYAA(c.454delGCC;A152del)和 CRYBB1(c.618C>A;Y206*)上有变异,与不明原因的先天性白内障有关。所有新的变异均被预测为致病性的,且具有中度或高度破坏性。
我们报告了 5 种新的变异和 5 种已知的变异。其中一些是罕见变异,以前在小的种族群体中报道过,但在这里我们将其扩展到更广泛的人群,并记录了这些变异的更广泛的表型谱。